BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20813773)

  • 41. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis.
    Bruce JM; Bruce AS; Arnett PA
    Neuropsychology; 2010 Jan; 24(1):77-83. PubMed ID: 20063948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of the MoCA test as a screening instrument in multiple sclerosis.
    Dagenais E; Rouleau I; Demers M; Jobin C; Roger E; Chamelian L; Duquette P
    Can J Neurol Sci; 2013 May; 40(3):410-5. PubMed ID: 23603179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological aspects of childhood multiple sclerosis: an overview.
    Blaschek A; Storm van's Gravesande K; Heinen F; Pritsch M; Mall V; Calabrese P
    Neuropediatrics; 2012 Aug; 43(4):176-83. PubMed ID: 22605613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatigue-related diurnal variations of cognitive performance in multiple sclerosis and stroke patients.
    Claros-Salinas D; Bratzke D; Greitemann G; Nickisch N; Ochs L; Schröter H
    J Neurol Sci; 2010 Aug; 295(1-2):75-81. PubMed ID: 20510427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of recruitment and participation bias in neuropsychological research among MS patients.
    Duquin JA; Parmenter BA; Benedict RH
    J Int Neuropsychol Soc; 2008 May; 14(3):494-8. PubMed ID: 18419848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cognitive functions in multiple sclerosis].
    Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM
    Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Models of cognitive deficit and statistical hypotheses: multiple sclerosis, an example.
    Ryan L; Clark CM; Klonoff H; Paty D
    J Clin Exp Neuropsychol; 1993 Jul; 15(4):563-77. PubMed ID: 8354709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29).
    Smedal T; Johansen HH; Myhr KM; Strand LI
    Acta Neurol Scand; 2010 Oct; 122(4):244-51. PubMed ID: 19951267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Memory impairment in multiple sclerosis and its determinant factors.
    Sedighi B
    Neurosciences (Riyadh); 2011 Jan; 16(1):24-8. PubMed ID: 21206441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple sclerosis and cognitive impairment].
    Nishiyama H; Kuroiwa Y
    Nihon Rinsho; 2004 Jan; 62 Suppl():298-301. PubMed ID: 15011370
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Gromisch ES; Portnoy JG; Foley FW
    J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apathy in multiple sclerosis: a validation study of the apathy evaluation scale.
    Raimo S; Trojano L; Spitaleri D; Petretta V; Grossi D; Santangelo G
    J Neurol Sci; 2014 Dec; 347(1-2):295-300. PubMed ID: 25455303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cognitive impairment in multiple sclerosis. State of research and methodological issues].
    Lembach Y; Adler G
    Fortschr Neurol Psychiatr; 2014 May; 82(5):280-97; quiz 298. PubMed ID: 24824207
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of two brief neuropsychological batteries in people with multiple sclerosis.
    Solari A; Mancuso L; Motta A; Mendozzi L; Serrati C
    Mult Scler; 2002 Apr; 8(2):169-76. PubMed ID: 11990875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.